Finally, we assessed the impact of APOB inactivating variants on the risk of ASCVD, providing an indirect yet balanced assessment of the benefits and potential drawbacks associated with the APOB‐linked low LDL‐C phenotype. This evidence concerns the gene APOB and atherosclerosis.